PDB Short entry for 1P2W HEADER HORMONE/GROWTH FACTOR INHIBITOR 16-APR-03 1P2W TITLE SOMATOSTATIN [HOMO SAPIENS] COMPND MOL_ID: 1; COMPND 2 MOLECULE: SOMATOSTATIN; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN KEYWDS SOMATOSTATIN EXPDTA THEORETICAL MODEL AUTHOR Y.B.VADDAVALLI,GEMEIOSYS RESEARCH LABS REVDAT 1 29-APR-03 1P2W 0 JRNL AUTH Y.B.VADDAVALLI,GEMEIOSYS RESEARCH LABS JRNL TITL SOMATOSTATIN [HOMO SAPIENS] JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ABINITIO PREDICTION REMARK 4 REMARK 4 1P2W COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-APR-2003. REMARK 100 THE RCSB ID CODE IS RCSB018943. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 CB SER A 27 CE1 PHE A 52 1.16 REMARK 500 CE MET A 1 CA LYS A 106 1.25 REMARK 500 CE MET A 1 CB LYS A 106 1.42 REMARK 500 CB ALA A 103 CE2 PHE A 113 1.52 REMARK 500 O PRO A 94 CD PRO A 98 1.55 REMARK 500 CE MET A 96 CE1 PHE A 109 1.56 REMARK 500 SD MET A 1 CA LYS A 106 1.59 REMARK 500 OD1 ASN A 91 OD1 ASN A 107 1.61 REMARK 500 O LEU A 56 CD PRO A 60 1.62 REMARK 500 CE MET A 1 C LYS A 106 1.70 REMARK 500 CZ PHE A 34 CG GLU A 55 1.74 REMARK 500 CE MET A 96 CD1 PHE A 109 1.81 REMARK 500 CB MET A 1 CD LYS A 106 1.84 REMARK 500 CB ALA A 103 CD2 PHE A 113 1.87 REMARK 500 O LEU A 56 CG PRO A 60 1.90 REMARK 500 OE1 GLN A 87 CB PHE A 109 1.96 REMARK 500 CB ALA A 25 OD2 ASP A 28 2.00 REMARK 500 CD2 LEU A 84 CE1 PHE A 108 2.00 REMARK 500 N LEU A 2 NZ LYS A 106 2.02 REMARK 500 CB ALA A 25 OD1 ASP A 28 2.02 REMARK 500 CE MET A 1 N ASN A 107 2.04 REMARK 500 C LEU A 2 NZ LYS A 106 2.06 REMARK 500 CB SER A 27 CD1 PHE A 52 2.06 REMARK 500 SD MET A 1 CG LYS A 106 2.07 REMARK 500 CB ALA A 25 CG ASP A 28 2.07 REMARK 500 O PHE A 108 CE1 PHE A 113 2.07 REMARK 500 SD MET A 1 CB LYS A 106 2.09 REMARK 500 CA LEU A 2 NZ LYS A 106 2.10 REMARK 500 CB SER A 27 CZ PHE A 52 2.13 REMARK 500 N SER A 3 NZ LYS A 106 2.14 REMARK 500 CA MET A 1 CD LYS A 106 2.19 REMARK 500 N CYS A 21 O GLY A 24 2.19 REMARK 500 O THR A 112 N CYS A 116 2.19 DBREF 1P2W A 1 116 UNP P01166 SMS_HUMAN 1 116 SEQRES 1 A 116 MET LEU SER CYS ARG LEU GLN CYS ALA LEU ALA ALA LEU SEQRES 2 A 116 SER ILE VAL LEU ALA LEU GLY CYS VAL THR GLY ALA PRO SEQRES 3 A 116 SER ASP PRO ARG LEU ARG GLN PHE LEU GLN LYS SER LEU SEQRES 4 A 116 ALA ALA ALA ALA GLY LYS GLN GLU LEU ALA LYS TYR PHE SEQRES 5 A 116 LEU ALA GLU LEU LEU SER GLU PRO ASN GLN THR GLU ASN SEQRES 6 A 116 ASP ALA LEU GLU PRO GLU ASP LEU SER GLN ALA ALA GLU SEQRES 7 A 116 GLN ASP GLU MET ARG LEU GLU LEU GLN ARG SER ALA ASN SEQRES 8 A 116 SER ASN PRO ALA MET ALA PRO ARG GLU ARG LYS ALA GLY SEQRES 9 A 116 CYS LYS ASN PHE PHE TRP LYS THR PHE THR SER CYS HELIX 1 1 LEU A 10 VAL A 16 1 7 HELIX 2 2 SER A 27 SER A 38 1 12 HELIX 3 3 GLY A 44 GLN A 46 5 3 HELIX 4 4 GLU A 47 LEU A 57 1 11 HELIX 5 5 GLU A 69 ARG A 88 1 20 HELIX 6 6 SER A 89 SER A 92 5 4 HELIX 7 7 ALA A 95 GLY A 104 1 10 HELIX 8 8 PHE A 109 PHE A 113 5 5 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000